Axon Enterprise vs National Presto Industries
AXON and NPK side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXON and NPK compare
Axon Enterprise is the larger company, worth 33 times as much as National Presto Industries ($34.8B against $1.1B).
Axon Enterprise grew revenue faster over the last twelve months (34.6% versus 20.9% for National Presto Industries).
National Presto Industries keeps more of each dollar of sales as profit, with a net margin of 7.9% compared with 6.2% at Axon Enterprise.
National Presto Industries pays a dividend yielding 0.68%; Axon Enterprise does not pay one.
National Presto Industries scores higher on the StockData Score (16 against 6 for Axon Enterprise), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXON | NPK |
|---|---|---|
| Size and price | ||
| Market cap | $34.8B | $1.1B |
| Share price | $427.77 | $147.82 |
| Change, 1 year | −43.7% | 38.2% |
| Change, 5 years | 134% | 67.4% |
| Beta (5Y) | 1.49 | 0.64 |
| Employees | 5,100 | 1,200 |
| StockData Score | ||
| Total score | 6 | 16 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 | 3 |
| Performance score | 1 | 3 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 177× | – |
| P/S | 10.8× | 1.9× (better) |
| P/B | 9.5× | 2.6× (better) |
| EV/EBITDA | 269× | 19.8× (better) |
| P/FCF | 261× | 39.9× (better) |
| FCF yield | 0.38% | 2.5% (better) |
| Fair value | $74.82 | $107.23 |
| Margin of safety | −472% | −37.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 34.6% (better) | 20.9% |
| Revenue growth, 5Y average | 32.5% (better) | 7.4% |
| Net income growth (TTM) | −38.9% | 3.0% (better) |
| EPS growth (TTM) | −40.3% | – |
| Profitability | ||
| Gross margin | 59.4% (better) | 16.5% |
| Operating margin | 0.74% | 9.6% (better) |
| Net margin | 6.2% | 7.9% (better) |
| FCF margin | 4.1% | 4.9% (better) |
| Return on equity | 6.2% | 10.9% (better) |
| Return on invested capital | 0.65% | 10.8% (better) |
| Financial health | ||
| Debt / equity | 0.47 (better) | 0.00 |
| Net debt / EBITDA | 7.81 | – |
| Interest coverage | 0.2× | – |
| Current ratio | 2.15 | 5.22 (better) |
| Altman Z-score | 6.39 | 10.58 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.68% |
| Payout ratio | – | 16.7% |
| Shareholder yield | 0.00% | 0.68% (better) |
| Ownership | ||
| Held by institutions | 89.1% | 61.4% |
| Held by insiders | 5.4% | 28.1% |
| Insider net buying, 12 months | −$130M | −$418K (better) |
| Short interest, % of float | 5.1% | 3.4% |
Go deeper
- AXON stock overview
- AXON income statement
- AXON valuation and score
- NPK stock overview
- NPK income statement
- NPK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.